EASTBOURNE CAPITAL MANAGEMENT LLC/CA Insider Trading $MBVX MABVAX THERAPEUTICS HOLDINGS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for EASTBOURNE CAPITAL MANAGEMENT LLC/CA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of EASTBOURNE CAPITAL MANAGEMENT LLC/CA. EASTBOURNE CAPITAL MANAGEMENT LLC/CA is 10% Owner in AMYLIN PHARMACEUTICALS INC ($AMLN) and 10% Owner in MGIC INVESTMENT CORP ($MTG) and 10% Owner in Sarepta Therapeutics, Inc. ($SRPT) and 10% Owner in PAIN THERAPEUTICS INC ($PTIE) and 10% Owner in MABVAX THERAPEUTICS HOLDINGS, INC. ($MBVX).
EASTBOURNE CAPITAL MANAGEMENT LLC/CA in MABVAX THERAPEUTICS HOLDINGS, INC.
Trading Symbol: MBVXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of EASTBOURNE CAPITAL MANAGEMENT LLC/CA: 10% Owner
Holdings: 11,850,000 shares
Current Value: $35,194,500
Latest Transaction: Sep 30 2009
$MBVX Market Capitalization: $18.01M
$MBVX Previous Close: $2.97
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of EASTBOURNE CAPITAL MANAGEMENT LLC/CA in MABVAX THERAPEUTICS HOLDINGS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AMLN, SAVA, MBVX, MTG, SRPT
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 30 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 0.81 | 300 | 244 | 11,850,000 | 11.9 M to 11.9 M (0.00 %) |
Sep 30 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 0.79 | 47,085 | 37,329 | 11,850,300 | 11.9 M to 11.9 M (-0.40 %) |
Sep 30 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 0.81 | 42,168 | 34,337 | 11,897,385 | 11.9 M to 11.9 M (-0.35 %) |
Sep 30 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 0.81 | 100,900 | 82,042 | 11,939,553 | 12 M to 11.9 M (-0.84 %) |
Sep 30 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 0.89 | 7,900 | 6,995 | 12,040,453 | 12 M to 12 M (-0.07 %) |
Sep 30 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 0.84 | 205,647 | 172,394 | 12,048,353 | 12.3 M to 12 M (-1.68 %) |
Sep 23 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 0.99 | 5,900 | 5,825 | 12,254,000 | 12.3 M to 12.3 M (-0.05 %) |
Sep 23 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 0.96 | 75,000 | 71,625 | 12,259,900 | 12.3 M to 12.3 M (-0.61 %) |
Sep 23 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 0.90 | 77,589 | 69,582 | 12,334,900 | 12.4 M to 12.3 M (-0.63 %) |
Sep 23 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 0.86 | 790,049 | 679,916 | 12,412,489 | 13.2 M to 12.4 M (-5.98 %) |
Sep 23 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 0.99 | 110,253 | 109,095 | 13,202,538 | 13.3 M to 13.2 M (-0.83 %) |
Sep 23 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 0.99 | 16,400 | 16,190 | 13,312,791 | 13.3 M to 13.3 M (-0.12 %) |
Sep 18 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 1.19 | 15,800 | 18,725 | 13,329,191 | 13.3 M to 13.3 M (-0.12 %) |
Sep 18 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 1.20 | 25,300 | 30,264 | 13,344,991 | 13.4 M to 13.3 M (-0.19 %) |
Sep 18 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 1.20 | 104,709 | 125,159 | 13,370,291 | 13.5 M to 13.4 M (-0.78 %) |
Feb 17 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.46 | 27,422 | 12,477 | 13,475,000 | 13.4 M to 13.5 M (+0.20 %) |
Feb 12 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.44 | 126,202 | 56,135 | 13,447,578 | 13.3 M to 13.4 M (+0.95 %) |
Feb 12 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.46 | 10,990 | 5,000 | 13,321,376 | 13.3 M to 13.3 M (+0.08 %) |
Feb 12 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.46 | 11,492 | 5,229 | 13,310,386 | 13.3 M to 13.3 M (+0.09 %) |
Feb 12 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.46 | 15,040 | 6,843 | 13,298,894 | 13.3 M to 13.3 M (+0.11 %) |
Feb 12 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.46 | 27,500 | 12,513 | 13,283,854 | 13.3 M to 13.3 M (+0.21 %) |
Feb 12 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.46 | 900 | 410 | 13,256,354 | 13.3 M to 13.3 M (+0.01 %) |
Feb 03 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.46 | 13,757 | 6,259 | 13,255,454 | 13.2 M to 13.3 M (+0.10 %) |
Feb 03 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.46 | 17,403 | 7,918 | 13,241,697 | 13.2 M to 13.2 M (+0.13 %) |
Feb 03 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.46 | 2,400 | 1,092 | 13,224,294 | 13.2 M to 13.2 M (+0.02 %) |
Feb 03 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.46 | 11,217 | 5,104 | 13,221,894 | 13.2 M to 13.2 M (+0.08 %) |
Jan 29 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.48 | 2,400 | 1,140 | 13,210,677 | 13.2 M to 13.2 M (+0.02 %) |
Jan 29 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.46 | 5,100 | 2,354 | 13,208,277 | 13.2 M to 13.2 M (+0.04 %) |
Jan 29 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.48 | 511 | 243 | 13,203,177 | 13.2 M to 13.2 M (0.00 %) |
Jan 29 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.46 | 38,174 | 17,369 | 13,202,666 | 13.2 M to 13.2 M (+0.29 %) |
Jan 29 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.48 | 22,875 | 10,866 | 13,164,492 | 13.1 M to 13.2 M (+0.17 %) |
Jan 29 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.48 | 1,600 | 760 | 13,141,617 | 13.1 M to 13.1 M (+0.01 %) |
Jan 22 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.51 | 186,453 | 94,849 | 13,140,017 | 13 M to 13.1 M (+1.44 %) |
Jan 22 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.45 | 104,580 | 47,051 | 12,953,564 | 12.8 M to 13 M (+0.81 %) |
Jan 22 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.50 | 31,776 | 16,012 | 12,848,984 | 12.8 M to 12.8 M (+0.25 %) |
Jan 22 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.46 | 26,847 | 12,261 | 12,817,208 | 12.8 M to 12.8 M (+0.21 %) |
Jan 22 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.45 | 2,719 | 1,230 | 12,790,361 | 12.8 M to 12.8 M (+0.02 %) |
Jan 15 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.46 | 67,755 | 31,201 | 12,787,642 | 12.7 M to 12.8 M (+0.53 %) |
Jan 15 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.45 | 19,730 | 8,948 | 12,719,887 | 12.7 M to 12.7 M (+0.16 %) |
Jan 15 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.40 | 4,000 | 1,580 | 12,700,157 | 12.7 M to 12.7 M (+0.03 %) |
Jan 15 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.40 | 36,273 | 14,328 | 12,696,157 | 12.7 M to 12.7 M (+0.29 %) |
Jan 05 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.39 | 25,000 | 9,625 | 12,659,884 | 12.6 M to 12.7 M (+0.20 %) |
Jan 05 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.38 | 1,343 | 508 | 12,634,884 | 12.6 M to 12.6 M (+0.01 %) |
Jan 05 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.39 | 79,354 | 30,908 | 12,633,541 | 12.6 M to 12.6 M (+0.63 %) |
Jan 05 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.36 | 3,800 | 1,382 | 12,554,187 | 12.6 M to 12.6 M (+0.03 %) |
Jan 05 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.37 | 6,400 | 2,368 | 12,550,387 | 12.5 M to 12.6 M (+0.05 %) |
Jan 05 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.38 | 18,512 | 7,062 | 12,543,987 | 12.5 M to 12.5 M (+0.15 %) |
Jan 05 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.35 | 3,400 | 1,173 | 12,525,475 | 12.5 M to 12.5 M (+0.03 %) |
Jan 05 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.36 | 55,020 | 19,681 | 12,522,075 | 12.5 M to 12.5 M (+0.44 %) |
Jan 05 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.38 | 263,708 | 99,813 | 12,467,055 | 12.2 M to 12.5 M (+2.16 %) |
Jan 05 2009 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.36 | 166,962 | 59,272 | 12,203,347 | 12 M to 12.2 M (+1.39 %) |
Dec 31 2008 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.35 | 255,980 | 90,566 | 12,036,385 | 11.8 M to 12 M (+2.17 %) |
Dec 31 2008 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.34 | 10,984 | 3,730 | 11,780,405 | 11.8 M to 11.8 M (+0.09 %) |
Dec 31 2008 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.36 | 147,850 | 52,487 | 11,769,421 | 11.6 M to 11.8 M (+1.27 %) |
Dec 31 2008 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.30 | 3,300 | 974 | 11,621,571 | 11.6 M to 11.6 M (+0.03 %) |
Dec 31 2008 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.35 | 62,303 | 21,519 | 11,618,271 | 11.6 M to 11.6 M (+0.54 %) |
Dec 31 2008 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Buy | P | 0.32 | 80,968 | 25,683 | 11,555,968 | 11.5 M to 11.6 M (+0.71 %) |
Jun 25 2008 | MBVX | MABVAX THERAPEUTIC ... | EASTBOURNE CAPITAL MANAGEMENT ... | 10% Owner | Sell | S | 1.26 | 4,261,019 | 5,368,884 | 11,475,000 | 15.7 M to 11.5 M (-27.08 %) |
Page: 1